As XRP attempts to defend a crucial support level, an analyst has called for a 30%-40% rally in the coming weeks, suggesting that the altcoin could see short-term relief before it reaches its 'critical inflection point.'
Big Hit Music, the music label run by BTS' management agency HYBE, announced that BTS' new comeback album "Arirang" sold 3.98 million copies on its first day of release.
DiaSorin S.p.A. reported a decline in its net result for fiscal year 2025 to 150 million euros, despite an increase in net revenues to 1.195 billion euros. The Board approved a dividend of 1.30 euros per share, with expectations for revenue growth of 5% to 6% for fiscal year 2026.
Markets are experiencing significant losses, but there are indicators suggesting a potential reversal. The Put-Call Ratio based on Open Interest (PCR OI) may provide insights into market sentiment and reversal opportunities.
Wall Street ended sharply lower as the U.S.-Israeli war against Iran deepened inflation worries, with the S&P 500 closing at its lowest in six months.
The first oil from US President Donald Trump’s planned 172 million-barrel emergency release is set to start flowing soon, as part of efforts to keep fuel prices in check amid rising retail gasoline prices and political pressure ahead of the midterm elections.
Bitcoin is holding steady as gold experiences a significant crash, with gold prices down over $1,100 from its record high, marking its worst weekly drop since 1983.
On-chain data shows that Bitcoin sharks and whales have increased their population by 3.9% over the last three months, despite a downtrend in Bitcoin's price.
Australia's Qantas Airways has fuel supplies that will last well into April, CEO Vanessa Hudson said in a memo to employees, despite rising jet fuel prices due to the Iran war.
Mustang Energy Corp. announces the completion of its plan of arrangement to spin out its Ford Lake property, with a share distribution record date set for March 26, 2026.
Sun Pharmaceutical Industries Ltd launches its Semaglutide injection under the brand names NovelTreat and Sematrinity in India.
Trump says US is close to achieving objectives Iran war but rejects ceasefire as Strait of Hormuz disruptions drive oil prices higher while stock futures fall.
Gold tumbled another 3.5% to $4,488 per ounce on Friday, marking an 11% fall for the week and the largest weekly loss the precious metal has seen since 1983 as geopolitical instability and uncertainty in the Middle East continue to weigh on the markets.
Zydus Lifesciences Ltd launches Semaglutide injection in a reusable multi-dose pen device in India, priced at 2,200 rupees per month.
Pentagon reportedly adopts Palantir's Maven as official program of record, securing long-term funding for AI weapons-targeting platform used in military strikes.
Grayscale argues that Zcash could challenge Bitcoin's dominance, suggesting an 18x upside if it captures a small market share due to its unique privacy features.
Mexican real estate investment trust Fibra Park Life plans to debut on the domestic stock market on March 31 with an initial public offering worth approximately 308 million pesos.
S&P Dow Jones Indices announced that Vita Coco Company Inc. will replace TEGNA Inc. in the S&P SmallCap 600 effective March 25.
Dr Reddy's Laboratories Ltd launches India's first DCGI-approved semaglutide injection Obeda for type 2 diabetes, priced at 4,200 rupees per month.
A jury found Elon Musk liable for misleading Twitter investors over bot claims in the $44 billion deal, risking up to $2.5 billion in damages.
As XRP attempts to defend a crucial support level, an analyst has called for a 30%-40% rally in the coming weeks, suggesting that the altcoin could see short-term relief before it reaches its “critical inflection point.”
On Friday, XRP saw a 2.5% intraday retrace to retest the $1.43 area before bouncing above the crucial $1.40 level. The altcoin has been hovering between $1.34-$1.50 over the past month, recently attempting to break out of the range’s upper boundary.
During this week’s market rally, the cryptocurrency surged 15% from the weekend lows, reaching a one-month high of $1.60 on Tuesday. However, broader market volatility has pulled XRP back into its local range, leading the altcoin to retest a crucial area.
Analyst ChardNerd affirmed that the altcoin is “currently defending a lifeline as it clings to support” and that he expects continuation to what he believes will be its “critical inflection point” in the coming weeks.
XRP has been trading around its 200-Week Exponential Moving Average (EMA), currently at $1.41, with multiple closes below it and a bullish reclaim above this level in the latest weekly candle.
As he explained, this is the key guardrail that the cryptocurrency must defend as the end of the week approaches, as it would set the stage for a new retest and potential reclaim of its $1.50 resistance and a relief rally toward two crucial levels above, the 20 EMA and 50 EMA.
“So, what I’m trying to say is XRP could potentially have some sort of relief in the coming months, up towards these EMAs, which sit between $1.80 and $2.00. And if it gets this relief, that will mark a very critical inflection point.”
He further emphasized that XRP must defend and hold the 200 EMA, as it has reclaimed the critical support level in the weekly timeframe and pushed the price toward its recent local highs.
Diving deeper into the potential upcoming relief rally, the analyst observed that in previous cycles, XRP also had a “very interestingly unfolding price action.”
He noted that after peaking in 2021, the altcoin fell to the 200 EMA, saw a relief rally toward the 20 and 50 EMA before being rejected and ultimately dropping to its bear market lows.
Now, the cryptocurrency has done “exactly what we did in the prior cycle peak in 2021,” significantly retracing from its July 2025 peak and falling back to the 200 EMA.
Notably, the altcoin saw around three months of relief after the successful back test, which could signal that “this is where we could see the next sort of few months, if Bitcoin behaves.”
Moreover, the previous relief rally took place around March 2022, ChardNerd asserted, noting that “It doesn’t have to repeat the exact same way.” If the March relief rally doesn’t retest the $1.80-$2.00 in the next week, the analyst suggested that “there is a possibility that it lasts a bit longer than it did the prior cycle” and continues into April or May.
“So, this is why there’s still the potential, I think, to get the push to $2 and then XRP comes back to $0.80 to $0.70,” he concluded.
